scispace - formally typeset
C

Chris Sander

Researcher at Harvard University

Publications -  730
Citations -  273726

Chris Sander is an academic researcher from Harvard University. The author has contributed to research in topics: Large Hadron Collider & Protein structure. The author has an hindex of 178, co-authored 713 publications receiving 233287 citations. Previous affiliations of Chris Sander include Purdue University & University of Leeds.

Papers
More filters

Additional file 1: Figures S1â S25. of Tumor immune microenvironment characterization in clear cell renal cell carcinoma identifies prognostic and immunotherapeutically relevant messenger RNA signatures

Yasin ĹenbabaoÄlu, +28 more
TL;DR: It is observed that the immunogenicity of ccRCC tumors cannot be explained by mutation load or neo-antigen load, but is highly correlated with MHC class I antigen presenting machinery expression (APM).
Journal ArticleDOI

Characterization of HPV and host genome interactions in primary head and neck cancers.

Michael Parfenov, +314 more
- 28 Oct 2014 - 
TL;DR: A cohort of 279 head and neck cancers with next generation RNA and DNA sequencing is profiled to provide insight into the mechanisms by which HPV interacts with the human genome beyond expression of viral oncoproteins and suggest that specific integration events are an integral component of viraloncogenesis.
Journal ArticleDOI

A large domain common to sperm receptors (Zp2 and Zp3) and TGF-β type III receptor

Peer Bork, +1 more
- 06 Apr 1992 - 
TL;DR: The results lead to the hypothesis that this type of domain has a common tertiary structure and that there is a functional similarity in the recognition mechanism of the sperm receptor system and the TGF‐β receptor complex.
Journal ArticleDOI

Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

Matthew A. Bailey, +761 more
- 09 Aug 2018 - 
TL;DR: In this article, the authors made two errors in preparation of this manuscript and corrected them in the revised Figure S7 by re-ordering the mutations by frequency for COAD and READ independently.
Journal ArticleDOI

Adverse outcomes in clear cell renal cell carcinoma with mutations of 3p21 epigenetic regulators BAP1 and SETD2: a report by MSKCC and the KIRC TCGA research network.

A. Ari Hakimi, +15 more
- 15 Jun 2013 - 
TL;DR: The chromosome 3p21 locus harbors 3 frequently mutated ccRCC tumor suppressor genes, and BAP1 and SETD2 mutations are associated with worse CSS, suggesting their roles in disease progression.